IL6 and nasopharyngeal carcinoma: found that RERG inhibited tumor growth and angiogenesis by down-regulating MMP2, MMP9, IL-6, and IL-8, and suppressed ERK/NF-κB signaling pathway in nasopharyngeal carcinoma xenografts in nude mice [31].